What You Should Know: – Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients. – Most remote cardiac monitors are passive […]

Biotricity, a California-based healthcare technology company, has received FDA clearance for its new three-lead electrocardiogram (ECG) and arrhythmia monitoring solution. The Biotres Cardiac Monitoring Device was built to help monitor the cardiac health of low-risk patients. It includes Bluetooth connectivity, a rechargeable battery and an adjustable design that can be updated in the future as […]

Aristea Therapeutics is on a rescue mission. The San Diego-based immunology company is using its considerable expertise and experience to locate and develop molecules where the mechanism of action has either been proven or makes sense. Of particular focus for Aristea, which spun out from AstraZeneca in 2018, is finding valuable therapeutics for rare inflammatory diseases. One such […]